Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

Xavier PalardJulien EdelineYan RollandSamuel Le SourdMarc PrachtSophie LaffontLaurence LenoirKarim BoudjemaThomas UgenVanessa BrunHabiba MesbahLaure-Anne HaumontPascal LoyerEtienne Garin

Published in: European journal of nuclear medicine and molecular imaging (2017)

This study demonstrates for the first time that HILD is significantly associated with liver hypertrophy. There is also an impact of high tumor doses in large lesions in one subgroup of patients. Larger prospective studies evaluating the MAA dosimetric parameters have to be conducted to confirm these promising results.

Keyphrases

radiation therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
randomized controlled trial
clinical trial
study protocol
liver metastases
patient reported